Press release
Illumina Genomics Forum to Feature Nobel Laureate Frances Arnold as part of Distinguished Panel on How the Genomics Revolution Is Transforming Patient Care
Speakers will discuss how genomics drives more informed, inclusive, and proactive care SAN DIEGO, Sept. 19, 2022 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN),
About this update from Illumina, Inc.
[{"type":"text","content":"Speakers will discuss how genomics drives more informed, inclusive, and proactive care\nSAN DIEGO, Sept. 19, 2022 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will convene a panel titled \"Clinical Genomics Is Now. Are You Ready?\" at its inaugural Illumina Genomics Forum (IGF), moderated by Nobel laureate and chemical engineer Frances Arnold of the California Institute of Technology. The September 28 roundtable will focus on genomics' role in transforming human health and the next steps in bridging research and clinical genomics.\n\n \n \n \n \n \n \n\n \n\"We are honored to have Nobel laureate Frances Arnold join our remarkable lineup of genomics and health care leaders to guide this important discussion demonstrating the spectrum of clinical utility now and the exciting road ahead,\" said Kathryne Reeves, chief marketing officer of Illumina. \"Genomics is transforming medical care today in ways we could not imagine just a few years ago, and I look forward to hearing from these distinguished thought leaders on how we can scale the power of genomics to advance health equity across the world.\"\nFeaturing visionary voices from across the health ecosystem, the panel will focus on groundbreaking applications of genomics in the health care industry today as well as the future possibilities of leveraging genomic medicine at scale. Each panelist will share powerful examples of how genomic integration is improving human health and advancing global health equity, as well as their vision for improving the standard of care for patients around the world.\nModerated by Frances Arnold, Nobel laureate and Linus Pauling Professor of Chemical Engineering, Bioengineering and Biochemistry at the California Institute of Technology, the panel will include:\nAmy Compton-Phillips, Former Executive Vice President and Chief Clinical Officer, Providence Health & ServicesJavier de EchevarrÃa, Chief Executive Officer and Co-founder, Veritas IntercontinentalCatalina Lopez-Correa, Chief Scientific Officer, Genome CanadaEric Topol, Founder and Director, Scripps Research Translational InstituteJay Wohlgemuth, Senior Vice President of Research & Development and Chief Medical Officer, Quest DiagnosticsIllumina previously announced that former US President Barack Obama will...